search
Back to results

Diaphragmatic Ultrasound in Acute Hypoxic - Hypercapnic Respiratory Failure (ARF) (DiaDea)

Primary Purpose

Acute Hypoxic - Hypercapnic Respiratory Failure (ARF)

Status
Completed
Phase
Not Applicable
Locations
Italy
Study Type
Interventional
Intervention
D-US ARF
Sponsored by
Azienda Ospedaliero Universitaria Maggiore della Carita
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional diagnostic trial for Acute Hypoxic - Hypercapnic Respiratory Failure (ARF) focused on measuring Ultrasound, Diaphragm, Non Invasive Ventilation

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • respiratory failure resulting in respiratory acidosis to be treated with NIV
  • Age> = 18 years

Exclusion Criteria:

  • acute pulmonary edema
  • coexisting interstitial pathologies
  • neuromuscular pathologies
  • thoracic cage's deformity
  • previous diaphragmatic paralysis
  • hemodynamic instability
  • intracranial hypertension
  • pregnancy
  • absolute contraindications to NIV
  • need for immediate intubation,
  • recent thoracotomy
  • presence of pneumothorax or pneumomediastinum

Sites / Locations

  • A.O.U Maggiore della Carità

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

D-US ARF

Arm Description

Diaphragmatic evaluation, i.e thickening fraction (%) and excursion (millimeters), will be performed 3 times in the first two hours after acute hypoxic - hypercapnic respiratory failure (ARF) patients admission

Outcomes

Primary Outcome Measures

Feasibility of diaphragm ultrasound function evaluation (excursion and thickening) in acute hypoxic - hypercapnic respiratory failure (ARF) during the first two hours after emergency department admission.
Ultrasound will be performed before starting NIV, after 1 and 2 two hours of NIV application

Secondary Outcome Measures

Arterial blood carbon dioxide (PaCO2) compensation evaluation
PaCO2 at time of starting NIV, after one hour from NIV application and after two hours of NIV application
Arterial blood carbon dioxide (PaCO2) compensation evaluation
PaCO2 at time of starting NIV, after one hour from NIV application
Arterial blood carbon dioxide (PaCO2) compensation evaluation
PaCO2 after two hours from NIV application
Monitoring diaphragmatic function in terms of thickening at 0 hour
Diaphragmatic thickening (%) [(inspiratory thickness - expiratory thickness)]/expiratory thickness * 100
Monitoring diaphragmatic function in terms of thickening at 1 hour
Diaphragmatic thickening (%) [(inspiratory thickness - expiratory thickness)]/expiratory thickness * 100
Monitoring diaphragmatic function in terms of thickening at 2 hours
Diaphragmatic thickening (%) [(inspiratory thickness - expiratory thickness)]/expiratory thickness * 100
Monitoring diaphragmatic function in terms of excursion at 0 hour
Diaphragmatic excursion (millimeters) computed as diaphragmatic displacement during breath
Monitoring diaphragmatic function in terms of excursion at 1 hour
Diaphragmatic excursion (millimeters) computed as diaphragmatic displacement during breath
Monitoring diaphragmatic function in terms of excursion at 2 hours
Diaphragmatic excursion (millimeters) computed as diaphragmatic displacement during breath
Days spent in intensive care unit
Amount of days spent in ICU
Days spent in in hospital
Amount of days spent in hospital
dyspnea level at 0 hour
dyspnea level evaluated via visual analogical scale
dyspnea level at 1 hour
dyspnea level evaluated via visual analogical scale
dyspnea level at 2 hours
dyspnea level evaluated via visual analogical scale

Full Information

First Posted
September 22, 2017
Last Updated
May 3, 2018
Sponsor
Azienda Ospedaliero Universitaria Maggiore della Carita
search

1. Study Identification

Unique Protocol Identification Number
NCT03314883
Brief Title
Diaphragmatic Ultrasound in Acute Hypoxic - Hypercapnic Respiratory Failure (ARF)
Acronym
DiaDea
Official Title
Ultrasound Diaphragmatic Evaluation in Acute Hypoxic - Hypercapnic Respiratory Failure (ARF) Patients Undergoing Non Invasive Ventilation: A Pilot Feasibility Study
Study Type
Interventional

2. Study Status

Record Verification Date
May 2018
Overall Recruitment Status
Completed
Study Start Date
October 9, 2017 (Actual)
Primary Completion Date
May 4, 2018 (Actual)
Study Completion Date
May 4, 2018 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Azienda Ospedaliero Universitaria Maggiore della Carita

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Mortality of acute hypoxic - hypercapnic respiratory failure (ARF) patients underwent invasive mechanical ventilation is demonstrated to be higher than in patients who underwent only non invasive mechanical ventilation (NIV). There is an increased need to detect more predictive factors for NIV failure, in order to better identify patients most at risk of facing negative outcomes. The aim of this experimental pilot study is to evaluate the feasibility of the ultrasound of diaphragm in ARF patients underwent non invasive mechanical ventilation ( primary endpoint ). Furthermore the secondary aim is to observe any relationship between diaphragmatic function (excursion), diaphragmatic thickening and the timing of arterial blood gases (ABGs) compensation in patients with ARF undergoing NIV treatment; additional outcomes are: correlation with dyspnea level, time of mechanical ventilation, NIV failure, rate of tracheostomy, length of stay in ICU and in-hospital and 90-day mortality.
Detailed Description
Inclusion criteria: respiratory failure resulting in respiratory acidosis to be treated with NIV, age> = 18 years Exclusion criteria: acute pulmonary edema, coexisting interstitial pathologies, neuromuscular pathologies, thoracic cage's deformity, previous diaphragmatic paralysis, hemodynamic instability, intracranial hypertension, pregnancy, absolute contraindications to NIV, need for immediate intubation, recent thoracotomy, presence of pneumothorax or pneumomediastinum. After patient's triage, transfer to Shock Room and primary assessment by emergency department staff ,diaphragmatic ultrasound is performed when NIV indication is given. NIV is delivered with a facial mask; ventilation is set in NIV application, pressure support mode. Positive end expiratory pressure (PEEP) and Inspired oxygen fraction (FiO2) are adjusted to obtain a peripheral oxygen saturation (Spo2) between 88-92%. The pressure support is set to achieve a target volume of between 6-8 (ml / kg) and a respiratory rate < 30 respiratory acts per minute. Respectively one and two hours after starting NIV, diaphragmatic ultrasonography and ABGs analysis are again performed. NIV failure criteria are defined by the need for endotracheal intubation or by death. Criteria for NIV failure: unchanging or worsening blood gases despite NIV; need to protect airways due to neurological deterioration or massive secretions; haemodynamic instability or major electrocardiographic abnormalities; uncontrolled dyspnea and NIV intolerance/ refusal. General measures On admission clinical severity is recorded by Glasgow Coma Scale (GCS), Acute Physiology and Chronic Health Evaluation II Score (APACHE II). ABGs values ( PH, arterial oxygen tension (paO2), arterial carbon dioxide tension (paCo2), paO2/FiO2, bicarbonates (HCO3), lactate) will be recorded before NIV, at 1 hour and 2 hours later. Chest X-ray and peripheral blood sample (hemochrome with band cell count, C-reactive protein (CRP) and electrolytes) will be performed within 24 hours of admission. The presence of pneumonia, sepsis and previous treatment with systemic or inhaled steroids will be recorded. Diaphragm Ultrasound Ultrasound evaluation of diaphragm function is performed on admission before starting NIV, 1 hour and 2 hours later. Diaphragmatic function is assessed by a B-Mode ultrasound device connected to a linear probe ( 7-12 MHz) at the patient's bedside. Measurements are performed on a patient in supine position with a recessed back angle between 20 and 40 degrees. Probe position is set between 8th and 10th intercostal space on the mid axillary line to find the apposition zone of the diaphragm, where lung, diaphragm and abdominal parenchyma are identifiable. Diaphragmatic thickness is measured at end-inspiration ( Ti) and end- expiration (Te). The percentage change in diaphragmatic thickness (ΔTdi) is calculated as follows: ΔTdi % = (Ti- Te) / Te * 100 Measurements are performed three times and the average value of the three measurements is considered. Diaphragmatic excursion is also evaluated. Statistical analysis As it is an experimental pilot feasibility study, 20 patients will be initially enrolled. Descriptive statistics for continuous variables will be presented as median and interquartile. Non-parametric continuous variables will be evaluated by non-parametric Wilcoxon test (Mann-Whitney). Categorical variables will be evaluated by chi-square or Fisher's test. The influence of diaphragmatic thickening and muscle thickness on NIV failure, mortality and hospitalization's days wil be assessed through correlation analysis A P-value <0.05 will be considered significant.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Acute Hypoxic - Hypercapnic Respiratory Failure (ARF)
Keywords
Ultrasound, Diaphragm, Non Invasive Ventilation

7. Study Design

Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
21 (Actual)

8. Arms, Groups, and Interventions

Arm Title
D-US ARF
Arm Type
Experimental
Arm Description
Diaphragmatic evaluation, i.e thickening fraction (%) and excursion (millimeters), will be performed 3 times in the first two hours after acute hypoxic - hypercapnic respiratory failure (ARF) patients admission
Intervention Type
Diagnostic Test
Intervention Name(s)
D-US ARF
Intervention Description
Diaphragm ultrasound evaluation in acute hypoxic - hypercapnic respiratory failure (ARF) patients undergoing non invasive ventilation, with regard to thickening (%) and excursion (millimeters)
Primary Outcome Measure Information:
Title
Feasibility of diaphragm ultrasound function evaluation (excursion and thickening) in acute hypoxic - hypercapnic respiratory failure (ARF) during the first two hours after emergency department admission.
Description
Ultrasound will be performed before starting NIV, after 1 and 2 two hours of NIV application
Time Frame
2 hours
Secondary Outcome Measure Information:
Title
Arterial blood carbon dioxide (PaCO2) compensation evaluation
Description
PaCO2 at time of starting NIV, after one hour from NIV application and after two hours of NIV application
Time Frame
0 hour
Title
Arterial blood carbon dioxide (PaCO2) compensation evaluation
Description
PaCO2 at time of starting NIV, after one hour from NIV application
Time Frame
1 hour
Title
Arterial blood carbon dioxide (PaCO2) compensation evaluation
Description
PaCO2 after two hours from NIV application
Time Frame
2 hours
Title
Monitoring diaphragmatic function in terms of thickening at 0 hour
Description
Diaphragmatic thickening (%) [(inspiratory thickness - expiratory thickness)]/expiratory thickness * 100
Time Frame
0 hour
Title
Monitoring diaphragmatic function in terms of thickening at 1 hour
Description
Diaphragmatic thickening (%) [(inspiratory thickness - expiratory thickness)]/expiratory thickness * 100
Time Frame
1 hour
Title
Monitoring diaphragmatic function in terms of thickening at 2 hours
Description
Diaphragmatic thickening (%) [(inspiratory thickness - expiratory thickness)]/expiratory thickness * 100
Time Frame
2 hours
Title
Monitoring diaphragmatic function in terms of excursion at 0 hour
Description
Diaphragmatic excursion (millimeters) computed as diaphragmatic displacement during breath
Time Frame
0 hour
Title
Monitoring diaphragmatic function in terms of excursion at 1 hour
Description
Diaphragmatic excursion (millimeters) computed as diaphragmatic displacement during breath
Time Frame
1 hour
Title
Monitoring diaphragmatic function in terms of excursion at 2 hours
Description
Diaphragmatic excursion (millimeters) computed as diaphragmatic displacement during breath
Time Frame
2 hours
Title
Days spent in intensive care unit
Description
Amount of days spent in ICU
Time Frame
28 days
Title
Days spent in in hospital
Description
Amount of days spent in hospital
Time Frame
90 days
Title
dyspnea level at 0 hour
Description
dyspnea level evaluated via visual analogical scale
Time Frame
0 hour
Title
dyspnea level at 1 hour
Description
dyspnea level evaluated via visual analogical scale
Time Frame
1 hour
Title
dyspnea level at 2 hours
Description
dyspnea level evaluated via visual analogical scale
Time Frame
2 hours
Other Pre-specified Outcome Measures:
Title
Relationship with mechanical ventilation length
Description
mechanical ventilation length expressed in days for both invasive and non invasive ventilation
Time Frame
28 days
Title
Mortality in intensive care unit
Description
Number of death in intensive care unit
Time Frame
28 days
Title
Tracheostomy
Description
Rate of tracheostomy (ratio between number of tracheostomy in study group)
Time Frame
28 days
Title
Relation with gravity index
Description
value of APACHE score in study population
Time Frame
24 hours
Title
Mortality in hospital
Description
Number of death in hospital
Time Frame
90 days

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: respiratory failure resulting in respiratory acidosis to be treated with NIV Age> = 18 years Exclusion Criteria: acute pulmonary edema coexisting interstitial pathologies neuromuscular pathologies thoracic cage's deformity previous diaphragmatic paralysis hemodynamic instability intracranial hypertension pregnancy absolute contraindications to NIV need for immediate intubation, recent thoracotomy presence of pneumothorax or pneumomediastinum
Facility Information:
Facility Name
A.O.U Maggiore della Carità
City
Novara
ZIP/Postal Code
28100
Country
Italy

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
31455684
Citation
Cammarota G, Sguazzotti I, Zanoni M, Messina A, Colombo D, Vignazia GL, Vetrugno L, Garofalo E, Bruni A, Navalesi P, Avanzi GC, Della Corte F, Volpicelli G, Vaschetto R. Diaphragmatic Ultrasound Assessment in Subjects With Acute Hypercapnic Respiratory Failure Admitted to the Emergency Department. Respir Care. 2019 Dec;64(12):1469-1477. doi: 10.4187/respcare.06803. Epub 2019 Aug 27.
Results Reference
derived

Learn more about this trial

Diaphragmatic Ultrasound in Acute Hypoxic - Hypercapnic Respiratory Failure (ARF)

We'll reach out to this number within 24 hrs